Jazz Pharmaceuticals Aktie
205,20
EUR
-3,50
EUR
-1,68
%
237,46
USD
-3,59
USD
-1,49
%
Jazz Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Jazz Pharmaceuticals Aktie Analyse
| 14.12.18 | Jazz Pharmaceuticals Peer Perform | Wolfe Research | |
| 23.03.18 | Jazz Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
| 05.12.17 | Jazz Pharmaceuticals Neutral | Mizuho | |
| 10.11.17 | Jazz Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
| 25.08.17 | Jazz Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
| 31.05.17 | Jazz Pharmaceuticals Neutral | Mizuho | |
| 06.04.17 | Jazz Pharmaceuticals Neutral | Mizuho | |
| 24.02.16 | Jazz Pharmaceuticals Neutral | Mizuho | |
|
Werbung
|
|||
| 10.11.15 | Jazz Pharmaceuticals Neutral | Mizuho | |
Werbung
Werbung